We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Best of the Best |

Top Accessed Article: Dermoscopic Examination of Nail Pigmentation FREE

Steven Q. Wang, MD
Arch Dermatol. 2012;148(6):752. doi:10.1001/archdermatol.2012.394.
Text Size: A A A
Published online

Ronger S, Touzet S, Ligeron C, et al. Dermoscopic examination of nail pigmentation. Arch Dermatol. 2002;138(10):1327-1333.

Accurate diagnosis of nail pigmentation can be a challenge. In the above article, Ronger and colleagues describe the dermoscopic features that are associated with melanoma, melanocytic nevus, ungula lentigo, drug-induced pigmentation, and subungal hemorrhage. For nail apparaturs melanoma, the most useful diagnostic criterion is the presence of irregularly colored line areas, with nonuniformed spacing between the lines and disruption of parallelism. In contrast, melanocytic nevus has lines that are regular in thickness, spacing, color, and parallelism. The main features of drug-induced pigmentation are a grayish coloration of the background and the presence of thin gray lines with regular thickness. Subungal hemorrhage can be recognized by the presence of blue to black structureless blood spots with rounded edges. These blood spots are commonly found in the periphery of the pigmentation. Armed with these specific dermoscopic patterns and clues, clinicians can increase the diagnostic accuracy of nail pigmentations that are associated with benign and malignant lesions. Finally, it is important to emphasize that dermoscopic examination does not replace histologic diagnosis. Biopsy should be performed in cases involving suspicious lesions.

From October 2010 to August 2011, this article was viewed 1915 times on the Archives of Dermatology Web site.


Contact Dr Wang at the Dermatology Division, Memorial Sloan Kettering Cancer Center, New York, New York (wangs@mskcc.org).





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.